Rick Maffei

[Breast Cancer: Targets and Therapy] Nanosomal docetaxel lipid suspension was developed to minimize toxicity issues associated with conventional docetaxel. The efficacy and safety of NDLS-based chemotherapy in breast cancer was evaluated in this retrospective study.

The following article features coverage from the American Society of Clinical Oncology 2020 virtual meeting. Click here to read more of Oncology Nurse Advisor‘s conference coverage.  

News coverage from the American Society of Clinical Oncology 2020 virtual meeting.

[Cancer Management and Research] Researchers present a comparison study on the sensitivity and accuracy of 3 types of imaging studies — contrast-enhanced ultrasound, MRI, and computed tomography — in diagnosing and classifying pancreatic cystic neoplasms.

The following article is part of the Oncology Nurse Advisor 10-year anniversary celebration. Click here to read more articles celebrating the milestone.  

The following article is part of the Oncology Nurse Advisor 10-year anniversary celebration. Click here to read more articles celebrating the milestone.  

[Oncotargets and Therapy] Some data support use of immunotherapy for breast cancer; however, as a monotherapy, only a small percentage of patients will benefit from the treatment. This review discusses the current status of efforts to improve immunotherapy through combinations with other therapies.

A review of our most popular articles from our 10 years of publication.

[Cancer Management and Research] This review focuses on how identification of molecular alterations and risk stratification would contribute to individualized-therapeutic decision-making in AML.

ONA celebrates a decade of service to oncology nursing.